Eli Lilly receives authorisation for Covid-19 antibody treatment
US FDA gives emergency approval to bamlanivimab therapy which is designed to boost immune system
Full Article
Eli Lilly receives authorisation for Covid-19 antibody treatment
FT.com
0 shares
1 views
You might like
Related news coverage
Which Covid vaccine candidates are competing against Pfizer?
Proactive Investors
The COVID-19 vaccine candidate developed by Pfizer Inc. (NYSE:PFE) and BioNTech (NASDAQ:BNTX) may be the closest to the finish..
-
Who is competing against Pfizer COVID-19 vaccine candidate?
Proactive Investors
-
Which Covid vaccine candidates are competing against Pfizer ?
Proactive Investors
-
Eli Lilly's COVID-19 antibody drug gets emergency approval in US
Mid-Day
-
Eli Lilly receives authorisation for COVID-19 antibody treatment
FXstreet.com